MYNZEPLI 40 MG/ML SOLUCION INYECTABLE EN VIAL

Advanz Pharma Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: ceb90405cb99f8d9
Drug Cima Aemps Name: MYNZEPLI 40 MG/ML SOLUCION INYECTABLE EN VIAL
Register Number: 1251964001
Holder Company Name: Advanz Pharma Limited
Marketing Company Name: Advanz Pharma Spain S.L.U.
Holder Company Detail Path: /organization/advanz-pharma-international-limited
Authorization Date: 2025-08-28
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 40 mg/ml
Route Of Administration: VÍA INTRAVÍTREA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Advanz Pharma Limited
Company Detail Path: /organization/advanz-pharma-international-limited

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 28, 2025

Approval ID

ceb90405cb99f8d9

Type

Standard